We investigated whether positive modulation of KCa3.1 by 1-ethyl-2-benzimidazolinone (1-EBIO) reversed the functional consequences of CALM1 knockdown in HD T cells (Coleman et al., 2014). This evidence concerns the gene KCNN4 and Huntington disease.